Emyria Ltd has released a press release.
Leadership Updates
Filed with ASX ·
On 6ix: 6ix.com/news/leadership-updates
6ix hasn’t read this filing yet.
Earlier from Emyria
- Emyria Secures $2.525M in Strongly Supported Placement
- Response to ASX Price Query
- Emyria & UWA Partner to License Novel Serotonin Therapies
- September 2024 Quarterly Activities Report and Appendix 4C
- Emyria Gains Ethics Endorsement for Psilocybin Program
Later from Emyria
- December 2024 Quarterly Activities Report and Appendix 4C
- Emyria Reports Promising 3-Month PTSD Treatment Results
- Emyria Opens New Empax Centre to Meet Demand and Payer Needs
- March 2025 Quarterly Activities Report and Appendix 4C
- PTSD Gains Sustained at 6m Follow-Up, MOU Signed with ANU
Follow Emyria into a list and get an email when it puts out news.
Follow Emyria